| Nardia Pharmaceuticals SA - Tranexamic Acid Nardia 500 mg/5 ml, soluzione iniettabile |
| 70581 | | 01 | | Tranexamic Acid Nardia 500 mg/5 ml | | soluzione iniettabile | | B02AA02 | | Tranexamsäure | | 19.02.2026 | | |
|
| Composition |
| acidum tranexamicum 500.0 mg, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Acidum Tranexamicum | 500 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 | | | B | | Non |
|
